(Q36752462)

16 August 2017

1 reference

21 June 2021

The current role of imaging for prostate brachytherapy (English)

1 reference

16 August 2017

1 reference

21 June 2021

1 reference

21 June 2021

1 reference

21 June 2021

Brendan Carey

1

1 reference

16 August 2017

Sarah Swift

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

28 February 2007

4 references

16 August 2017

3 April 2019

25 June 2019

21 June 2021

3 references

16 August 2017

25 June 2019

21 June 2021

7

1 reference

16 August 2017

27-33

1 reference

Diffusion-weighted magnetic resonance imaging and its application to cancer

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Results of permanent prostate brachytherapy, 13 years of experience at a single institution

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

The dosimetry of prostate brachytherapy-induced urethral strictures

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Regional heterogeneity in the brain's response to hypoxia measured using BOLD MR imaging

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Erectile function after permanent prostate brachytherapy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828366

Use of TRUS to predict pubic arch interference of prostate brachytherapy

5 September 2018

1 reference

12 December 2020

Rectal dosimetric analysis following prostate brachytherapy

1 reference

12 December 2020

Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy

1 reference

12 December 2020

Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion

1 reference

12 December 2020

Complications after prostate brachytherapy in the Medicare population

1 reference

12 December 2020

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA

1 reference

12 December 2020

Rectal fistulas after prostate brachytherapy

1 reference

12 December 2020

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time

1 reference

12 December 2020

Comparison of biochemical failure definitions for permanent prostate brachytherapy

1 reference

12 December 2020

Palladium-103 brachytherapy for prostate carcinoma

1 reference

12 December 2020

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

12 December 2020

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer

1 reference

12 December 2020

Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice

1 reference

12 December 2020

Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer

1 reference

12 December 2020

Rectal function following prostate brachytherapy

1 reference

12 December 2020

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

12 December 2020

Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer

1 reference

12 December 2020

Temporary PSA rises and repeat prostate biopsies after brachytherapy

1 reference

12 December 2020

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

12 December 2020

Prostate-specific antigen spikes after permanent prostate brachytherapy

1 reference

12 December 2020

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

12 December 2020

10.1102/1470-7330.2007.0003

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

17339141

1 reference